NCT00812643View on ClinicalTrials.gov

Excretion of Radiolabelled AZD0837

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions

Healthy

Interventions

DRUG

AZD0837

Oral solution, dosing through the Loc-I-Gut catheter, single dose

Trial Locations (1)

Unknown

Research Site, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY